Cargando…
A novel multikinase inhibitor SKLB‐YTH‐60 ameliorates inflammation and fibrosis in bleomycin‐induced lung fibrosis mouse models
OBJECTIVES: Idiopathic pulmonary fibrosis (IPF) is marked by the excessive accumulation of extracellular matrix, which participates in a variety of chronic diseases or injuries and seriously threatens human health. Due to the side effects of clinical drugs, there is still a need to develop novel and...
Autores principales: | Liu, Hongyao, Wu, Xiuli, Gan, Cailing, Wang, Liqun, Wang, Guan, Yue, Lin, Liu, Zhihao, Wei, Wei, Su, Xingping, Zhang, Qianyu, Tan, Zui, Yao, Yuqin, Ouyang, Liang, Yu, Luoting, Ye, Tinghong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249783/ https://www.ncbi.nlm.nih.gov/pubmed/34121240 http://dx.doi.org/10.1111/cpr.13081 |
Ejemplares similares
-
Nifuroxazide ameliorates pulmonary fibrosis by blocking myofibroblast genesis: a drug repurposing study
por: Gan, Cailing, et al.
Publicado: (2022) -
Synthesis and biological evaluation of indazole derivatives as anti-cancer agents
por: Wei, Wei, et al.
Publicado: (2021) -
Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy
por: Tan, Zui, et al.
Publicado: (2021) -
Blueberry Juice Attenuates Pulmonary Fibrosis via Blocking the TGF-β1/Smad Signaling Pathway
por: Li, Yali, et al.
Publicado: (2022) -
Niclosamide-loaded nanoparticles (Ncl-NPs) reverse pulmonary fibrosis in vivo and in vitro
por: Gan, Cailing, et al.
Publicado: (2022)